Improving drug development with a vast map of the immune system
Immunai, founded by two researchers from MIT, is helping pharmaceutical companies identify the patients that stand to benefit most from new treatments.
Danny Wells Luis Voloch Ansu Satpathy Stanford University Tel Aviv University Parker Institute For Cancer Immunotherapy
Source: mit.edu